Amundi Asset Management US’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
GCM
CCM
RIM
SCA
KCM
Amundi Asset Management US's LMAT Position: Q1 2021 in Review
Amundi Asset Management US reduced its LeMaitre Vascular (LMAT) stake by 12% in Q1 2021, selling an estimated $1.85M and leaving 276,829 shares worth $13.5M. The position accounts for 0.01% of the portfolio, ranked #767.
Amundi Asset Management US first reported a position in LMAT in Q2 2019 and has held it in 8 quarters since. The position peaked at $17.6M in Q2 2019. 179 funds tracked by Wall St. Rank hold LMAT as of Q1 2021.
- Amundi Asset Management US held 276,829 shares of LeMaitre Vascular worth $13.5M as of Q1 2021.
- Amundi Asset Management US sold 39,452 LeMaitre Vascular shares in Q1 2021, an estimated $1.85M.
- LeMaitre Vascular made up 0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #767 holding.
- Amundi Asset Management US first reported a position in LeMaitre Vascular in Q2 2019 and has held it in 8 quarters since.
- Amundi Asset Management US's LeMaitre Vascular position peaked at $17.6M in Q2 2019.
- 179 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2021.
Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.